Mexico Aims to Become a Global Leader in the Regulation of Biologic, Biosimilar Medicines

The pharmaceutical market in Mexico remains the second most attractive in Latin America. The Economist Intelligence Unit projects a weak exchange rate for the Mexican peso in the forecast period, which will affect the value of the Mexican pharmaceutical market in U.S. dollar terms.
Business Review USA